Growth Metrics

Cme (CME) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Cme (CME) over the last 17 years, with Q3 2025 value amounting to $187.1 billion.

  • Cme's Liabilities and Shareholders Equity rose 3581.37% to $187.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $662.3 billion, marking a year-over-year increase of 2665.65%. This contributed to the annual value of $137.4 billion for FY2024, which is 596.8% up from last year.
  • According to the latest figures from Q3 2025, Cme's Liabilities and Shareholders Equity is $187.1 billion, which was up 3581.37% from $179.9 billion recorded in Q2 2025.
  • Over the past 5 years, Cme's Liabilities and Shareholders Equity peaked at $205.9 billion during Q1 2022, and registered a low of $123.4 billion during Q2 2024.
  • Its 5-year average for Liabilities and Shareholders Equity is $162.4 billion, with a median of $166.0 billion in 2023.
  • Per our database at Business Quant, Cme's Liabilities and Shareholders Equity soared by 5785.41% in 2021 and then tumbled by 2960.99% in 2023.
  • Over the past 5 years, Cme's Liabilities and Shareholders Equity (Quarter) stood at $196.8 billion in 2021, then dropped by 11.49% to $174.2 billion in 2022, then decreased by 25.53% to $129.7 billion in 2023, then increased by 5.97% to $137.4 billion in 2024, then skyrocketed by 36.16% to $187.1 billion in 2025.
  • Its last three reported values are $187.1 billion in Q3 2025, $179.9 billion for Q2 2025, and $157.8 billion during Q1 2025.